related documents 121 The use of bisphosphonates in men with hormone-refractory prostate cancer: A systematic review of randomized trials Conferences 201 Anatomical variables may determine the value of IMRT in intermediate risk prostate cancer: A dosimetric evaluation between IMRT and 3D-CRT PLANS Conferences